每日經濟新聞(wen) 2022-08-15 20:59:47
每(mei)經AI快訊,佐(zuo)(zuo)(zuo)力藥(yao)業(SZ 300181,收(shou)盤價:9.28元(yuan)(yuan))8月(yue)15日晚間(jian)發布(bu)公(gong)告(gao)稱,為(wei)了(le)未來更好(hao)地實(shi)施“一體(ti)兩翼”發展(zhan)戰(zhan)略,做大(da)做強(qiang)中(zhong)(zhong)(zhong)(zhong)藥(yao)飲片(pian)和配方顆粒業務,同時進一步優化子公(gong)司(si)(si)(si)股(gu)(gu)權(quan)結構,提高(gao)管理決策效率,公(gong)司(si)(si)(si)與浙(zhe)江佐(zuo)(zuo)(zuo)力百(bai)草(cao)中(zhong)(zhong)(zhong)(zhong)藥(yao)飲片(pian)有(you)限(xian)公(gong)司(si)(si)(si)少數股(gu)(gu)東(dong)陳(chen)(chen)(chen)照榮先(xian)(xian)生(sheng)(sheng)、陳(chen)(chen)(chen)歡先(xian)(xian)生(sheng)(sheng)簽署了(le)《關于浙(zhe)江佐(zuo)(zuo)(zuo)力百(bai)草(cao)中(zhong)(zhong)(zhong)(zhong)藥(yao)飲片(pian)有(you)限(xian)公(gong)司(si)(si)(si)之股(gu)(gu)權(quan)轉讓協議》,公(gong)司(si)(si)(si)通過使用(yong)自有(you)資金7500萬元(yuan)(yuan)人(ren)民(min)(min)幣收(shou)購陳(chen)(chen)(chen)歡先(xian)(xian)生(sheng)(sheng)、陳(chen)(chen)(chen)照榮先(xian)(xian)生(sheng)(sheng)合計持(chi)有(you)佐(zuo)(zuo)(zuo)力百(bai)草(cao)中(zhong)(zhong)(zhong)(zhong)藥(yao)48.99%股(gu)(gu)權(quan),簡化股(gu)(gu)權(quan)結構。其中(zhong)(zhong)(zhong)(zhong),公(gong)司(si)(si)(si)以(yi)約(yue)4682萬元(yuan)(yuan)人(ren)民(min)(min)幣收(shou)購陳(chen)(chen)(chen)歡先(xian)(xian)生(sheng)(sheng)持(chi)有(you)佐(zuo)(zuo)(zuo)力百(bai)草(cao)中(zhong)(zhong)(zhong)(zhong)藥(yao)30.58%股(gu)(gu)權(quan);以(yi)約(yue)2818萬元(yuan)(yuan)人(ren)民(min)(min)幣收(shou)購陳(chen)(chen)(chen)照榮先(xian)(xian)生(sheng)(sheng)持(chi)有(you)佐(zuo)(zuo)(zuo)力百(bai)草(cao)中(zhong)(zhong)(zhong)(zhong)藥(yao)18.41%股(gu)(gu)權(quan)。本次交易完成后(hou),佐(zuo)(zuo)(zuo)力百(bai)草(cao)中(zhong)(zhong)(zhong)(zhong)藥(yao)將(jiang)成為(wei)公(gong)司(si)(si)(si)全資子公(gong)司(si)(si)(si),公(gong)司(si)(si)(si)持(chi)有(you)其100%股(gu)(gu)權(quan)。
2021年1至12月(yue)份,佐力藥業的營(ying)業收入構成為:醫藥制造(zao)占比90.52%,醫藥流通占比8.99%。
佐力藥業的董事長是(shi)俞(yu)有強,男(nan),60歲;總(zong)經理(li)是(shi)汪(wang)濤,男(nan),54歲,學歷背景為本(ben)科。
截(jie)至發稿,佐力藥業市(shi)值為56億元(yuan)。
道達(da)號(daoda1997)“個股趨勢(shi)”提醒:
1. 近30日內無機構對佐力藥業進行調研。
更多個股(gu)趨勢信息,請搜索微(wei)信公眾號“道(dao)達號”,回復“查詢”,領(ling)取(qu)免費查詢權限(xian)!
每經頭條(nbdtoutiao)——
(記者 蔡鼎)
免(mian)責聲明:本文內(nei)容(rong)與(yu)數據僅(jin)供參考,不構成(cheng)投資建議,使用(yong)前請核實。據此操作,風(feng)險自擔。
如需轉載請與《每日經濟新聞》報社聯系。
未經《每日(ri)經濟(ji)新聞》報社授權,嚴禁轉載或鏡像,違(wei)者(zhe)必究。
讀者熱線(xian):4008890008
特別提醒:如果我們使用了您的圖片,請作者與本站聯系索取(qu)稿酬。如您不希望作品(pin)出現在本站,可(ke)聯系我們(men)要求撤下您的作品(pin)。
歡迎關注每日經濟新聞APP